7th Jul 2006 16:53
Celsis International PLC07 July 2006 CELSIS INTERNATIONAL PLC 7 July 2006: Celsis International plc (the 'Company'), the rapid diagnostics andanalytical services company, today announces that a copy of the followingdocuments have been submitted to the UK Listing Authority, and will shortly beavailable for inspection at the UK Listing Authority's Document ViewingFacility, which is situated at the Financial Services Authority, 25 The NorthColonnade, Canary Wharf, London E14 5HS, telephone no. 020 7066 1000. Annual Report and Accounts for the year ended 2006Notice of Annual General Meeting 2006Form of Proxy for the 2006 Annual General Meeting Enquiries: Celsis International plc Tel: 01638 600 151Christian Madrolle, Finance Director & Company SecretaryJenny Parsons, Corporate Communications Financial Dynamics Tel: 020 7831 3113Ben AtwellAnna Keeble Notes to editors Celsis International plc Celsis International plc is a rapid diagnostics and analytical services company. The company is listed on the London Stock Exchange (CEL.L). Using proprietary technology, the Product Group is the world leader in theprovision of diagnostic systems for the rapid detection of microbialcontamination. It works in close collaboration with many of the world's leadingpharmaceutical, personal care and beverage companies, ensuring the safety andquality of products bound for consumers. The Laboratory Group providesoutsourced analytical testing services to pharmaceutical and biopharmaceuticalcompanies to ensure the stability and chemical composition of their products. In addition to ensuring product quality and safety for consumers, both divisionshave the capacity to deliver substantial cost savings to Celsis' customers. Byreducing the time it takes to test and release raw materials and finished goodsto the market place, Celsis' products facilitate increased manufacturingproductivity and improved supply chain management. Further information can be found on its website at www.celsis.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Celadon Pharmaceuticals